Uniza Group launches nutri supplement for diabetes in India

Ahmedabad-based Uniza Group has entered into an exclusive tie-up with Lysulin, Inc - headquartered in San Diego, US to launch Lysulin - a breakthrough evidence-based nutritional product for the Indian market. Lysulin is patented in the US for the prevention of protein glycation using Lysine supplements and as a method of diabetes support using a supplement. It helps manage blood sugar by binding naturally to the glucose in the blood and safely removing it from the body. When taken daily, the supplement has been clinically shown to help people with type 2 diabetes and prediabetes maintain healthy blood sugar and A1c levels. Uniza is a pharmaceutical venture of Pashupati Group. The company has set up a modern, state-of-the-art facility complying with WHO-GMP and PIC/S guidelines at Kadi near Ahmedabad, Gujarat. Having launched India business in August 2020, the company has gradually expanded its product range to over 80 SKU's with a sale of Rs 25 crore in the first year.